With a new month just around the corner, investors may be thinking about how to put fresh capital to work.
If you have $10,000 ready to invest this April, focusing on high-quality ASX 200 shares could be a smart move, especially after recent share market volatility.
Here are three ASX 200 shares that could be worth considering.
Image source: Getty Images
CSL Ltd (ASX: CSL)
CSL may be Australia's most established biotechnology company, but its shares have come under pressure in recent times.
A softer-than-expected half-year result and uncertainty following a CEO departure have weighed on sentiment. In particular, its core CSL Behring division has faced slower-than-expected margin recovery and softer immunoglobulin sales growth.
However, looking beyond the near-term challenges, CSL still has a powerful long-term investment case. It operates in a global plasma therapies market with high barriers to entry, supported by complex manufacturing processes and strict regulatory requirements.
With growing demand for plasma-derived therapies and contributions from its Seqirus and Vifor divisions, CSL appears well positioned to return to stronger earnings growth over time, especially if it is successful with its significant cost cutting plan.
For investors willing to be patient, the recent weakness could present an opportunity to gain exposure to a global healthcare leader at a more attractive valuation.
DroneShield Ltd (ASX: DRO)
DroneShield offers exposure to a very different theme. It develops counter-drone solutions designed to detect and neutralise unmanned aerial threats. With geopolitical tensions rising globally, demand for these types of technologies is increasing rapidly.
DroneShield has been winning new contracts and expanding its footprint across key international markets. Its solutions are being adopted by military, government, and critical infrastructure customers.
While it remains a higher-risk investment compared to more established blue chips, its growth potential is significant if it continues to scale successfully.
For investors looking to allocate a portion of their $10,000 to a higher-growth opportunity, DroneShield could be worth a closer look.
Xero Ltd (ASX: XRO)
Xero is another ASX 200 share that could be a compelling option for long-term investors.
The cloud-based accounting platform has built a strong position among small and medium-sized businesses, offering subscription-based software that generates recurring revenue.
One of Xero's key strengths is its scalability. As it adds more subscribers and expands into new markets, its revenue base can grow while maintaining attractive margins.
The company also continues to invest in product innovation and ecosystem development, helping to deepen customer engagement and increase lifetime value.
Although its shares have been volatile during the recent market selloff, Xero's long-term growth outlook remains intact.
For investors seeking exposure to a high-quality technology business with global ambitions, Xero could be a strong candidate for a buy-and-hold strategy.
